Embryonal rhabdomyosarcoma of the uterine cervix is an uncommon presentation of the most common soft-tissue sarcoma in the first decades of life. Unlike embryonal rhabdomyosarcoma in other anatomic ...
CONCLUSION: IRS-IV therapy benefited certain subgroups of patients with intermediate-risk embryonal rhabdomyosarcoma. A doubling of the intensity of cyclophosphamide (or ifosfamide equivalent) dosing ...
Current knowledge suggests that tumors arise from muscle progenitor cells. "Through our studies on human embryonal rhabdomyosarcoma tumor cells, we found that the levels of the transcriptional ...
RMS is the most common soft tissue tumor of childhood and accounts for 5% of all malignant tumors in patients <15 y of age (1). Although historically reported survival rates are poor, survival has ...
To find new treatment approaches for childhood cancer, scientists at St. Jude Children's Research Hospital are digging deep into disease biology to target a process long considered "undruggable." The ...
Study coordinators who want to add a study should Submit a Clinical Trial. For more information or to remove a study, please email pa-webteam@bcm.edu. MyChart is a ...
Adding 6 months of maintenance chemotherapy appears to improve survival for patients with high-risk rhabdomyosarcoma (RMS) and will be the new standard of care in future European clinical trials, ...
An international consortium of pediatric oncology experts has published consensus guidelines on radiation treatment for children with metastatic rhabdomyosarcoma (RMS), offering site-specific ...
Cervical rhabdomyosarcoma is an aggressive cancer that can affect both children and adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results